(Q44971239)

7 December 2017

title

Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program (English)

1 reference

7 December 2017

5

1 reference

7 December 2017

Davide Castagno

4

0 references

Pardeep S. Jhund

object named as

Pardeep Jhund

series ordinal

3

0 references

Christopher B. Granger

series ordinal

8

object named as

Christopher B Granger

1 reference

7 December 2017

7

Karl Swedberg

1 reference

7 December 2017

6

Salim Yusuf

1 reference

7 December 2017

9

John J V McMurray

1 reference

7 December 2017

10

Marc A Pfeffer

1 reference

7 December 2017

2

Brian Claggett

1 reference

7 December 2017

Ali Vazir

1

1 reference

7 December 2017

Scott D Solomon

series ordinal

11

1 reference

7 December 2017

publication date

2 November 2014

1 reference

7 December 2017

published in

European Heart Journal

1 reference

7 December 2017

volume

36

1 reference

7 December 2017

issue

11

1 reference

7 December 2017

page(s)

669-675

1 reference

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Resting heart rate in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Mode of death in heart failure: findings from the ATLAS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Elevated heart rate: a major risk factor for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Temporal changes in resting heart rate and deaths from ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Resting heart rate pattern during follow-up and mortality in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Predictors of mortality and morbidity in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Secular trends in heart rate in young adults, 1949 to 2004: analyses of cross sectional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

Is heart rate important for patients with heart failure in atrial fibrillation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU401

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHU401

1 reference

7 December 2017

1 reference